Blood components: current challenges

Transfus Clin Biol. 2007 Dec;14(6):496-8. doi: 10.1016/j.tracli.2008.02.004. Epub 2008 Apr 16.

Abstract

Labile blood products are still here to stay for quite a long time. All European surveys come in agreement to reveal that indications, extremely heterogeneous from one country to another, are not fully under control. Both the EuroNet-TMS network and Euro'SAT congresses aim at improving the use of such products within an evidence-based medicine perspective.

MeSH terms

  • Biological Products / standards*
  • Blood Component Removal / statistics & numerical data
  • Blood Transfusion / standards*
  • Europe
  • European Union
  • Humans

Substances

  • Biological Products